Pediatrix Medical Group, Inc.

NYSE:MD 株式レポート

時価総額:US$1.2b

Pediatrix Medical Group マネジメント

マネジメント 基準チェック /34

Pediatrix Medical Groupの CEO はJim Swiftで、 Jan2023年に任命され、 の在任期間は 1.83年です。 の年間総報酬は$ 2.24Mで、 29%給与と71%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.2%を直接所有しており、その価値は$ 2.46M 。経営陣と取締役会の平均在任期間はそれぞれ2.1年と4.3年です。

主要情報

Jim Swift

最高経営責任者

US$2.2m

報酬総額

CEO給与比率29.0%
CEO在任期間1.8yrs
CEOの所有権0.2%
経営陣の平均在職期間2.1yrs
取締役会の平均在任期間4.3yrs

経営陣の近況

Recent updates

Pediatrix Medical Group: The Business Is Turning

Nov 18

Pediatrix Medical Group, Inc. (NYSE:MD) Shares Fly 27% But Investors Aren't Buying For Growth

Nov 06
Pediatrix Medical Group, Inc. (NYSE:MD) Shares Fly 27% But Investors Aren't Buying For Growth

Here's Why Pediatrix Medical Group (NYSE:MD) Has A Meaningful Debt Burden

Oct 19
Here's Why Pediatrix Medical Group (NYSE:MD) Has A Meaningful Debt Burden

We Like These Underlying Return On Capital Trends At Pediatrix Medical Group (NYSE:MD)

Sep 28
We Like These Underlying Return On Capital Trends At Pediatrix Medical Group (NYSE:MD)

Improved Revenues Required Before Pediatrix Medical Group, Inc. (NYSE:MD) Stock's 32% Jump Looks Justified

Aug 07
Improved Revenues Required Before Pediatrix Medical Group, Inc. (NYSE:MD) Stock's 32% Jump Looks Justified

Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?

Jun 19
Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?

Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger

May 10
Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger

Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking

Mar 29
Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking

Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price

Jan 10
Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price

Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors

Dec 25
Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors

Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?

Nov 14
Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?

Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?

Oct 13
Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?

Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?

Aug 09
Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?

Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold

Aug 08

At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?

Jul 03
At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?

The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing

Jun 08
The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing

Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet

Apr 26
Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet

Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?

Feb 20
Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?

Pediatrix Medical Group Q4 2022 Earnings Preview

Feb 16

Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?

Jan 12
Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?

Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold

Dec 22

Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing

Dec 20
Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing

Pediatrix appoints James Swift as chief executive officer

Dec 15

Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

Nov 05
Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11, revenue of $489.92M misses by $21.54M

Nov 03

Pediatrix: These 5 Graphs Suggest It's A Buy

Sep 29

Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly

Sep 13
Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly

Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return

Aug 29
Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return

Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

Jul 27
Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

Pediatrix: Seeking 46% Return Objective As Speculative Buy

Jul 14

MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate

Jun 24
MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate

MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet

May 25
MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet

Return Trends At MEDNAX (NYSE:MD) Aren't Appealing

Apr 20
Return Trends At MEDNAX (NYSE:MD) Aren't Appealing

MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price

Mar 08
MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price

MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly

Feb 15
MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly

CEO報酬分析

Pediatrix Medical Group の収益と比較して、Jim Swift の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$254m

Jun 30 2024n/an/a

-US$252m

Mar 31 2024n/an/a

-US$71m

Dec 31 2023US$2mUS$650k

-US$60m

Sep 30 2023n/an/a

US$88m

Jun 30 2023n/an/a

US$95m

Mar 31 2023n/an/a

US$98m

Dec 31 2022US$1mUS$450k

US$63m

報酬と市場: Jimの 総報酬 ($USD 2.24M ) は、 US市場 ($USD 5.37M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Jimの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Jim Swift (62 yo)

1.8yrs

在職期間

US$2,237,839

報酬

Dr. James D. Swift, M.D., also known as Jim, is Director of Brave Care, Inc. since October 2021. He had been the Chief Operating Officer at Pediatrix Medical Group, Inc. since May 2022 until December 31, 2...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
James Swift
CEO & Director1.8yrsUS$2.24m0.20%
$ 2.5m
Mary Ann Moore
Chief Administrative Officer2.1yrsUS$1.83m0.18%
$ 2.2m
Kasandra Rossi
Executive VPless than a yearデータなし0.052%
$ 645.4k
John Pepia
Senior VP & Chief Accounting Officer8.5yrsUS$1.43mデータなし
Cheryl VanPatten
Senior VP & Chief Information Officer2.8yrsデータなしデータなし
Charles Lynch
Senior VP of Financeno dataデータなしデータなし
Meghan Lublin
Senior VP3.3yrsデータなしデータなし
Debra McRoberts
Senior Vice President of People Servicesless than a yearデータなしデータなし
Daniel Corcoran
Senior Vice President of Administration & Managed Careno dataデータなしデータなし
Mike Ashford
President of Regional Operations (Central)no dataデータなしデータなし
Michael Dwyer
President of Regional Operations (South-Central)no dataデータなしデータなし
Nanette Sanders
Senior Vice President of Operationsno dataデータなしデータなし

2.1yrs

平均在職期間

62yo

平均年齢

経験豊富な経営陣: MDの経営陣は 経験豊富 であると考えられます ( 2.1年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
James Swift
CEO & Director1.7yrsUS$2.24m0.20%
$ 2.5m
Mark Ordan
Chair4.3yrsUS$554.45k0.16%
$ 2.0m
Guy Sansone
Lead Independent Director4.3yrsUS$295.00k0.081%
$ 1.0m
Thomas McEachin
Independent Director4.3yrsUS$252.50k0.065%
$ 806.0k
Sylvia Young
Independent Director1.5yrsUS$201.00k0.035%
$ 430.6k
John Starcher
Independent Director4.3yrsUS$230.00k0.065%
$ 805.9k
Shirley Weis
Independent Director4.3yrsUS$245.00k0.043%
$ 531.4k
Gavin Molinelli
Board Observer4.3yrsデータなしデータなし
Michael Rucker
Independent Director5.5yrsUS$242.50k0.069%
$ 857.7k
Laura Linynsky
Independent Director2.5yrsUS$230.00k0.023%
$ 286.9k

4.3yrs

平均在職期間

61yo

平均年齢

経験豊富なボード: MDの 取締役会経験豊富 であると考えられます ( 4.3年の平均在任期間)。